Artificial Intelligence in Pharmacy: A Boon for Drug Delivery & Drug Discovery

Artificial Intelligence (AI) is increasingly recognized as a game-changer in the pharmaceutical industry, especially in the fields of drug discovery and drug delivery. The integration of Artificial Intelligence (AI) into pharmacy practices represents a transformative advancement in drug delivery systems. Recent pharmaceutical research shows that significantly evolved artificial intelligence (AI) and machine learning Techniques are promising to facilitate the drug delivery system development. The intersection of artificial intelligence (AI) and pharmacy has ushered in a new era of drug delivery, marked by unprecedented precision, efficiency, and personalization. AI, with its ability to process vast amounts of data, identify patterns, and make intelligent decisions, is revolutionizing various aspects of drug development, manufacturing, and distribution. This paper explores the profound impact AI technologies are having on the optimization of pharmaceutical delivery mechanisms. By examining recent innovations and case studies, this presentation elucidates how AI is revolutionizing drug delivery, offering a substantial boon to pharmaceutical practice and patient care. AI can process big data, reveal potential correlations, provide accurate predictions, and navigate in a high-dimensional space, offering great potential to change the drug delivery research paradigm. Data-driven approaches can be applied to all aspects of the pharmaceutical field, across preformulation studies, formulation screening, and precision medicine in the clinic. Personalized medicine approaches can be facilitated through AI algorithms that analyze real-world patient data, leading to more effective treatment outcomes and improved patient adherence. Artificial Intelligence (AI) is revolutionizing the field of drug discovery by enhancing the efficiency, accuracy, and speed of identifying potential drug candidates. AI technologies, such as machine learning, deep learning, and natural language processing, are being increasingly integrated into various stages of drug discovery, including target identification, compound screening, lead optimization, and clinical trial design. This review explores the transformative potential of AI, focusing on how it is revolutionizing both the discovery of new drugs and the optimization of drug delivery systems.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-04
DOI
https://doi.org/10.5281/zenodo.14272917
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial Intelligence in Pharmacy: A Boon for Drug Delivery & Drug Discovery

Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

Artificial Intelligence in Pharmacy: A Boon for Drug Delivery & Drug Discovery

article en

Abstract

Artificial Intelligence (AI) is increasingly recognized as a game-changer in the pharmaceutical industry, especially in the fields of drug discovery and drug delivery. The integration of Artificial Intelligence (AI) into pharmacy practices represents a transformative advancement in drug delivery systems. Recent pharmaceutical research shows that significantly evolved artificial intelligence (AI) and machine learning Techniques are promising to facilitate the drug delivery system development. The intersection of artificial intelligence (AI) and pharmacy has ushered in a new era of drug delivery, marked by unprecedented precision, efficiency, and personalization. AI, with its ability to process vast amounts of data, identify patterns, and make intelligent decisions, is revolutionizing various aspects of drug development, manufacturing, and distribution. This paper explores the profound impact AI technologies are having on the optimization of pharmaceutical delivery mechanisms. By examining recent innovations and case studies, this presentation elucidates how AI is revolutionizing drug delivery, offering a substantial boon to pharmaceutical practice and patient care. AI can process big data, reveal potential correlations, provide accurate predictions, and navigate in a high-dimensional space, offering great potential to change the drug delivery research paradigm. Data-driven approaches can be applied to all aspects of the pharmaceutical field, across preformulation studies, formulation screening, and precision medicine in the clinic. Personalized medicine approaches can be facilitated through AI algorithms that analyze real-world patient data, leading to more effective treatment outcomes and improved patient adherence. Artificial Intelligence (AI) is revolutionizing the field of drug discovery by enhancing the efficiency, accuracy, and speed of identifying potential drug candidates. AI technologies, such as machine learning, deep learning, and natural language processing, are being increasingly integrated into various stages of drug discovery, including target identification, compound screening, lead optimization, and clinical trial design. This review explores the transformative potential of AI, focusing on how it is revolutionizing both the discovery of new drugs and the optimization of drug delivery systems.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 53%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Artificial Intelligence in Pharmacy: A Boon for Drug Delivery & Drug Discovery · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS